M. Haas et al., RENAL TARGETING OF A NONSTEROIDAL ANTIINFLAMMATORY DRUG - EFFECTS ON RENAL PROSTAGLANDIN SYNTHESIS IN THE RAT, Clinical science, 95(5), 1998, pp. 603-609
1, Renal specific targeting of the non-steroidal anti-inflammatory dru
g naproxen was obtained by coupling to the low-molecular-mass protein
lysozyme. A previous study showed that conjugation to lysozyme resulte
d in a 70-fold increase of naproxen accumulation in the kidney with a
subsequent renal release of the active metabolite naproxen-lysine. 2.
In the present study we questioned whether naproxen-lysozyme is active
in the rat kidney, inhibiting the urinary excretion of prostaglandin
E-2 and renal sodium and water excretion in salt-restricted baseline c
onditions as well as during frusemide treatment. 3. A high dose of fre
e naproxen (10 mg . day(-1) . kg(-1)) did not affect prostaglandin E-2
excretion in baseline conditions (naproxen, 11 +/- 1 ng/8 h; vehicle,
13 +/- 4 ng/8 h), whereas sodium and water excretion were, respective
ly, 3.0 and 1.6 times lower in the naproxen group (P < 0.05). Naproxen
completely prevented the frusemide-induced increase (3-fold) in prost
aglandin E-2 excretion (naproxen 6.6 +/- 1.1 ng/8 h, vehicle 40 +/- 12
ng/8 h, P < 0.005). Frusemide-stimulated natriuresis and diuresis wer
e, respectively, 1.6 (P < 0.05) and 1.8 times (P < 0.005) lower in the
naproxen group. 4. A dose of 2 mg . day(-1) . kg(-1) lysozyme-conjuga
ted naproxen did not affect prostaglandin E-2 excretion in baseline co
nditions (conjugate, 18+/-2 ng/8 h; vehicle, 24+/-5 ng/8 h). The conju
gate also had no effect on sodium and water excretion. However, the na
proxen conjugate completely prevented the frusemide-induced increase (
2-fold) in prostaglandin E-2 excretion (conjugate, 16 +/- 3 ng/8 h; ve
hicle, 48 +/- 1 3 ng/8 h, P < 0.05). Surprisingly, frusemide-induced n
atriuresis and diuresis were not affected by the conjugate. 5. In conc
lusion, a renal specific delivery of the non-steroidal anti-inflammato
ry drug naproxen using lysozyme results in an inhibitory effect on ren
al prostaglandin E-2 synthesis but does not affect the excretion of so
dium and water, in contrast to free naproxen.